Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications

Area of Science:

• Biochemistry
• Analytical Chemistry
• Clinical Diagnostics

Background:

• Quantitative peptide analysis in biological fluids is vital for patient diagnosis and prognosis.
• Liquid chromatography-mass spectrometry (LC-MS) methods are increasingly favored over ligand-binding assays due to specificity.
• Top-down LC-MS analysis of intact peptides avoids issues associated with bottom-up digestion.

Purpose of the Study:

• To discuss analytical pitfalls in developing LC-MS methods for intact peptide quantification in biological fluids.
• To highlight challenges in pre-analytical steps, sample stability, and processing.
• To review emerging techniques and mass spectrometry roles in peptide analysis.

Main Methods:

• Discussion of analytical challenges in LC-MS method development for intact peptides.
• Review of pre-analytical phase considerations and sample stability.
• Exploration of microextraction techniques for sample cleanup and enrichment.
• Comparison of high-resolution and low-resolution mass spectrometry.
• Introduction of supercharging reagents for enhanced ionization.

Main Results:

• Pre-analytical phase challenges and sample stability significantly impact peptide quantification accuracy.
• Emerging techniques like microextractions improve sample cleanup and analyte enrichment.
• High-resolution mass spectrometry and supercharging reagents offer advantages in peptide analysis.

Conclusions:

• Accurate quantification of intact peptides in biological fluids via LC-MS faces numerous analytical challenges.
• Careful attention to pre-analytical steps, sample handling, and advanced techniques is essential for reliable results.
• Continued development in LC-MS technology, including high-resolution MS and ionization enhancement, is critical for advancing peptide-based diagnostics.